气道压力释放通气用于成人急性低氧性呼吸衰竭:系统评价与Meta分析
该系统评价与Meta分析纳入2000至2018年间发表的7项随机对照试验,共412例急性低氧性呼吸衰竭的危重成人,比较气道压力释放通气与任何通气模式。结果显示气道压力释放通气与显著死亡率获益相关(相对风险0.67;95%CI 0.48-0.94;I<0.1%;p=0.97),并改善第3天PaO2/FIO2比值(加权均数差60.4;95%CI 10.3-110.5)。启动包括吸入肺血管扩张剂、俯卧位通气或体外膜氧合在内的挽救治疗的需求无显著差异(相对风险0.51;95%CI 0.22-1.21;I=64.7%;p=0.04)。气压伤风险仅在三项研究中报告,组间无差异(相对风险0.39;95%CI 0.12-1.19;I<0.1%;p=0.99)。作者认为,鉴于纳入研究的患者数量有限,需要更大规模的多中心研究来验证这些发现。
要点
- 在急性低氧性呼吸衰竭的危重成人中,气道压力释放通气与传统通气策略相比,死亡率相对风险为0.67(95%CI 0.48-0.94)。
- 气道压力释放通气组第3天PaO2/FIO2比值较对照组提高,加权均数差为60.4(95%CI 10.3-110.5)。
- 启动挽救治疗(吸入肺血管扩张剂、俯卧位通气或体外膜氧合)的需求无显著差异,相对风险0.51(95%CI 0.22-1.21)。
- 气压伤风险仅在三项研究中报告,组间无显著差异,相对风险0.39(95%CI 0.12-1.19)。
- 作者指出纳入研究的患者数量有限,需要更大规模的多中心研究来验证这些发现。
适用人群与场景
- 急性低氧性呼吸衰竭的危重成人,需要机械通气。
- 纳入随机对照试验发表于2000至2018年间,比较气道压力释放通气与任何通气模式,并报告至少一项死亡率结局。
研究设计与关键结果
- 研究类型:系统评价与Meta分析,纳入7项随机对照试验,共412例患者。
- 主要终点:气道压力释放通气与传统通气策略相比,死亡率相对风险0.67(95%CI 0.48-0.94;I<0.1%;p=0.97)。
- 次要终点:第3天PaO2/FIO2比值加权均数差60.4(95%CI 10.3-110.5),气道压力释放通气组较对照组改善。
- 挽救治疗需求:包括吸入肺血管扩张剂、俯卧位通气或体外膜氧合,相对风险0.51(95%CI 0.22-1.21;I=64.7%;p=0.04),组间无显著差异。
- 不良事件:气压伤风险仅在三项研究中报告,相对风险0.39(95%CI 0.12-1.19;I<0.1%;p=0.99),组间无显著差异。
证据类型、等级与局限
- 证据类型:系统评价与Meta分析,纳入7项随机对照试验。
- 局限:作者指出纳入研究的患者数量有限,需要更大规模的多中心研究来验证这些发现。
对床旁实践的改变
- 作者认为,在因急性低氧性呼吸衰竭需要机械通气的成人患者中,与传统通气策略相比,气道压力释放通气与死亡率获益和氧合改善相关。
- 作者指出,鉴于纳入研究的患者数量有限,需要更大规模的多中心研究来验证这些发现。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVES: To evaluate the efficacy and safety of airway pressure release ventilation in critically ill adults with acute hypoxemic respiratory failure.
DATA SOURCES: A systematic literature search of MEDLINE via PUBMED, EMBASE, the Cochrane Library, published conference proceedings and abstracts, reference lists of eligible studies and review articles, and hand searches of relevant journals and trial registers.
STUDY SELECTION: Eligible studies included randomized controlled trials published between years 2000 and 2018, comparing airway pressure release ventilation to any ventilation mode, in critically ill adults with acute hypoxemic respiratory failure and reporting at least one mortality outcome.
DATA EXTRACTION: Screened citations were reviewed and extracted independently by two investigators onto a prespecified proforma.
DATA SYNTHESIS: There were 412 patients from seven randomized controlled trials included in the qualitative and quantitative data synthesis. Airway pressure release ventilation was associated with a significant mortality benefit (relative risk, 0.67; 95% CI, 0.48-0.94; I < 0.1%; p = 0.97) and improvement in day 3 PaO2/FIO2 ratio (weighted mean difference, 60.4; 95% CI, 10.3-110.5). There was no significant difference in requirement to initiate rescue treatments including inhaled pulmonary vasodilators, prone positioning, or extracorporeal membrane oxygenation (relative risk, 0.51; 95% CI, 0.22-1.21; I = 64.7%; p = 0.04). The risk of barotrauma was only reported in three studies and did not differ between groups (relative risk, 0.39; 95% CI, 0.12-1.19; I < 0.1%; p = 0.99).
CONCLUSIONS: In adult patients requiring mechanical ventilation for acute hypoxic respiratory failure, airway pressure release ventilation is associated with a mortality benefit and improved oxygenation when compared with conventional ventilation strategies. Given the limited number of patients enrolled in the available studies, larger multicenter studies are required to validate these findings.
参考来源
- Lim J, Litton E. Airway Pressure Release Ventilation in Adult Patients With Acute Hypoxemic Respiratory Failure: A Systematic Review and Meta-Analysis. Crit Care Med. 2019. PMID: 31517696. doi:10.1097/CCM.0000000000003972
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。